Skip to content

PARATEK PHARMACEUTICALS, INC.

CIK 0001178711

← back to feed
Revenue (TTM)
$131.08M
+2,571.1% YoY Q2 Jul 2023
Net Income (TTM)
−$73.2M
−97.1% YoY Q2 Jul 2023
EPS Diluted (TTM)
−$1.31
+4.1% YoY Q2 Jul 2023
Gross Margin
84.8%
Q2 Jul 2023
Operating Margin
-41.9%
Q2 Jul 2023
Net Margin
-55.8%
Q2 Jul 2023
Free Cash Flow (TTM)
−$59.88M
Q2 Jul 2023
Cash
$42.69M
Q2 Jul 2023
Total Debt
$258.33M
Q2 Jul 2023
Shares Outstanding
57.32M sh
Q2 Jul 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings